Focus on structure-guided drug discovery using virtual screening, docking, dynamics, pharmacophore modeling and ADME profiling. Combines computational chemistry with synthesis to develop leads from natural products and repurposed drugs across antiviral, cardiovascular, antimicrobial and ophthalmic targets.